AlumisALMS

Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders.

Ratings

0 / 5

0 ratings in the last 12 months

5
4
3
2
1

$679.9M

Market Cap • 17/07/2024

2021

(há 3 anos)
Fundação

2024

IPO

NASDAQ

Listagem
Flag of US

South San Francisco

Sede • California

Valuation

Valuation Indicators

Retorno Histórico

ALMSSó no Premium...

Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.

11%

1 dia

15/07/2024

-3%

1 semana

10/07/2024

10 anos

Histórico